133 related articles for article (PubMed ID: 6120500)
21. Subacute sepsis impairs vascular smooth muscle contractile machinery and alters vasoconstrictor and dilator mechanisms.
Price SA; Spain DA; Wilson MA; Harris PD; Garrison RN
J Surg Res; 1999 May; 83(1):75-80. PubMed ID: 10210646
[TBL] [Abstract][Full Text] [Related]
22. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
[TBL] [Abstract][Full Text] [Related]
24. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
Opie LH
Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
[TBL] [Abstract][Full Text] [Related]
25. Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors.
Timmermans PB; Chiu AT; Thoolen MJ
Can J Physiol Pharmacol; 1987 Aug; 65(8):1649-57. PubMed ID: 2891423
[TBL] [Abstract][Full Text] [Related]
26. Calcium antagonists. Some chemical-pharmacologic aspects.
Triggle DJ; Swamy VC
Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
[TBL] [Abstract][Full Text] [Related]
27. Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor.
Eiam-Ong S; Eiam-Ong S; Punsin P; Sitprija V; Chaiyabutr N
J Med Assoc Thai; 2004 Apr; 87(4):410-8. PubMed ID: 15217180
[TBL] [Abstract][Full Text] [Related]
28. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
[TBL] [Abstract][Full Text] [Related]
29. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
30. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
Kazda S; Garthoff B; Krause HP; Schlossmann K
Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
[TBL] [Abstract][Full Text] [Related]
31. Calcium antagonists--terminology, classification and comparison.
van Zwieten PA
Arzneimittelforschung; 1985; 35(1A):298-301. PubMed ID: 4039169
[TBL] [Abstract][Full Text] [Related]
32. Receptor subtypes involved in the action of calcium antagonists.
van Zwieten PA; Timmermans PB; van Heiningen PN
J Hypertens Suppl; 1987 Dec; 5(4):S21-8. PubMed ID: 2450185
[TBL] [Abstract][Full Text] [Related]
33. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
[TBL] [Abstract][Full Text] [Related]
34. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
Badawi JK; Langbein S
Pharmazie; 2006 Mar; 61(3):175-8. PubMed ID: 16599254
[TBL] [Abstract][Full Text] [Related]
35. Effects of barbiturates, phencyclidine, ketamine and analogs on cerebral circulation and cerebrovascular muscle.
Altura BT; Altura BM
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):169-84. PubMed ID: 6400429
[TBL] [Abstract][Full Text] [Related]
36. Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxyacetic acid 94) channel antagonists on alpha1-adrenoceptor mediated contractions in rat aorta.
Duggan JA; Tabrizchi R
Can J Physiol Pharmacol; 2000 Sep; 78(9):714-20. PubMed ID: 11007534
[TBL] [Abstract][Full Text] [Related]
37. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
[TBL] [Abstract][Full Text] [Related]
38. Alpha-adrenoceptor stimulation and calcium movements.
van Zwieten PA; Timmermans PB
Blood Vessels; 1987; 24(5):271-80. PubMed ID: 2441781
[TBL] [Abstract][Full Text] [Related]
39. [Effects of xinchuanling (XC-1) and its derivative XC-2 on adrenoceptors and arterial muscle].
Sun YD; Feng YP; Zeng GY; Song ZY
Yao Xue Xue Bao; 1987 Feb; 22(2):81-6. PubMed ID: 3039796
[No Abstract] [Full Text] [Related]
40. Calcium antagonists and vascular smooth muscle.
Flaim SF
Prog Clin Biol Res; 1986; 219():311-52. PubMed ID: 3786324
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
